ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,393.78
-0.36%
Dow Jones
39,806.77
0.00%
Gold vs US Dollar
2,423.445
-0.12%
Brent Oil
82.08
-1.74%
Bitcoin
71,189.30
-0.36%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Dicerna Pharmaceuticals Inc (DRNA)

  7. Dicerna Pharmaceuticals Inc (DRNA) News

Dicerna Pharmaceuticals (DRNA)

Dicerna Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DRNA
DateTimeSourceHeadlineSymbolCompany
14/02/202211:18Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:DRNADicerna Pharmaceuticals Inc
10/01/202222:00Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:DRNADicerna Pharmaceuticals Inc
03/01/202211:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:DRNADicerna Pharmaceuticals Inc
29/12/202121:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DRNADicerna Pharmaceuticals Inc
29/12/202121:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DRNADicerna Pharmaceuticals Inc
29/12/202121:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DRNADicerna Pharmaceuticals Inc
29/12/202121:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DRNADicerna Pharmaceuticals Inc
29/12/202121:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DRNADicerna Pharmaceuticals Inc
29/12/202121:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DRNADicerna Pharmaceuticals Inc
29/12/202121:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DRNADicerna Pharmaceuticals Inc
29/12/202121:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DRNADicerna Pharmaceuticals Inc
29/12/202121:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DRNADicerna Pharmaceuticals Inc
29/12/202121:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DRNADicerna Pharmaceuticals Inc
29/12/202121:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DRNADicerna Pharmaceuticals Inc
29/12/202121:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DRNADicerna Pharmaceuticals Inc
28/12/202116:18Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:DRNADicerna Pharmaceuticals Inc
28/12/202116:15Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:DRNADicerna Pharmaceuticals Inc
28/12/202116:14Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:DRNADicerna Pharmaceuticals Inc
28/12/202116:12Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:DRNADicerna Pharmaceuticals Inc
28/12/202116:11Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:DRNADicerna Pharmaceuticals Inc
28/12/202116:06Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:DRNADicerna Pharmaceuticals Inc
28/12/202116:04Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:DRNADicerna Pharmaceuticals Inc
28/12/202115:52Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:DRNADicerna Pharmaceuticals Inc
28/12/202115:47Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:DRNADicerna Pharmaceuticals Inc
28/12/202114:35Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:DRNADicerna Pharmaceuticals Inc
28/12/202114:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DRNADicerna Pharmaceuticals Inc
28/12/202114:04Business WireNovo Nordisk Announces Completion of Dicerna Pharmaceuticals AcquisitionNASDAQ:DRNADicerna Pharmaceuticals Inc
27/12/202113:08Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:DRNADicerna Pharmaceuticals Inc
27/12/202113:01Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:DRNADicerna Pharmaceuticals Inc
25/12/202113:00Business WireDicerna Announces Expiration of Hart-Scott-Rodino Act Waiting Period for Novo Nordisk Tender Offer to Acquire DicernaNASDAQ:DRNADicerna Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:DRNA

Your Recent History

LSE
POS
Plexus
LSE
VAL
Valirx
LSE
TERN
Tern
LSE
VAST
Vast Resources
LSE
PHE
Powerhouse Energy
LSE
SYME
Supply@me Capital
LSE
GKP
Gulf Keystone Petroleum
LSE
SOLG
Solgold
LSE
GGP
Greatland Gold
LSE
CHLL
Chill Brands
LSE
GOLD
LSE
KEFI
Kefi Gold And Copper
LSE
AAZ
Anglo Asian Mining
LSE
SCE
Surface Transforms
LSE
SCLP
Scancell
LSE
LLOY
Lloyds Banking
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved